Profile of HER2 +ve Gastric Cancers in Brunei Darussalam.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Asian Pacific Journal of Cancer Prevention

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 27268629
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New guidelines for HER2 pathological diagnostics in gastric cancer

  2016influential reference
• Survey of Her2-neu Expression and its Correlation with Histology of Gastric Carcinoma and Gastroesophageal Junction Adenocarcinoma.

  2015cited by this paper
• Declining trends in prevalence of Helicobacter pylori infection by birth‐year in a Japanese population

  2015cited by this paper
• Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?

  2015cited by this paper
• Screening of gastric cancer in Asia.

  2015cited by this paper
• A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond.

  2014cited by this paper
• Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray.

  2014cited by this paper
• Profiles of Epstein-Barr Virus Associated Gastric Carcinomas in Brunei Darussalam

  2014cited by this paper
• Gastric cancer in Brunei Darussalam: epidemiological trend over a 27 year period (1986-2012).

  2014cited by this paper
• Meta-analysis of six randomized control trials of chemotherapy plus anti-HER monoclonal antibody for advanced gastric and gastroesophageal cancer.

  2014cited by this paper
• HER2-positive gastric cancer

  2013cited by this paper
• HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature

  2012cited by this paper
• HER2 testing in gastric cancer: a practical approach

  2012influential reference
• Global cancer statistics

  2011cited by this paper
• HER2 Testing in Gastric Cancer

  2011cited by this paper
• HER2 Expression in Gastric Cancer: Rare, Heterogeneous and of No Prognostic Value – Conclusions from 924 Cases of Two Independent Series

  2010influential reference
• Targeted HER2 Treatment in Advanced Gastric Cancer

  2010cited by this paper
• Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

  2010influential reference
• Helicobacter pylori infection and correlation with upper gastrointestinal pathologies: an eleven-year trend.

  2009cited by this paper
• Trends in Helicobacter pylori Infection and Gastric Cancer in Mexico

  2005cited by this paper
• c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.

  2000influential reference

• The Role of Human Epidermal Growth Factor Receptor (HER2/neu) in the Prognosis of Patients with Gastric Cancer

  2019cites this paper
• Human epidermal growth factor receptor-2 assessment in cancerous and precancerous lesions of the stomach in presence of Helicobacter pylori

  2018influential citation
• Gastric Cancer: Biological Markers as Prognostic Factor

  2017cites this paper
• Clinicopathological factors associated with HER2-positive gastric cancer

  2017cites this paper
• GASTRIC CANCER: BIOLOGICAL MARKERS AS PROGNOSTIC FACTOR

  2017cites this paper